Psychology Associates Of Bethlehem, Pc - Medicare Mental Health Clinic in Bethlehem, PA

Psychology Associates Of Bethlehem, Pc is a medicare enrolled mental health clinic (Psychologist) in Bethlehem, Pennsylvania. The current practice location for Psychology Associates Of Bethlehem, Pc is 264 E Broad St, Bethlehem, Pennsylvania. For appointments, you can reach them via phone at (610) 866-9311. The mailing address for Psychology Associates Of Bethlehem, Pc is 264 E Broad St, Bethlehem, Pennsylvania and phone number is (610) 866-9311.

Psychology Associates Of Bethlehem, Pc is licensed to practice in Pennsylvania (license number PS005682L). The clinic also participates in the medicare program and its NPI number is 1518942655. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (610) 866-9311.

Contact Information

Psychology Associates Of Bethlehem, Pc
264 E Broad St
Bethlehem
PA 18018-6224
(610) 866-9311
(610) 882-2072

Mental Health Clinic Profile

Full NamePsychology Associates Of Bethlehem, Pc
SpecialityPsychologist
Location264 E Broad St, Bethlehem, Pennsylvania
Authorized Official Name and PositionJoanne M Regina (CEO)
Authorized Official Contact6108669311
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Psychology Associates Of Bethlehem, Pc
264 E Broad St
Bethlehem
PA 18018-6224

Ph: (610) 866-9311
Psychology Associates Of Bethlehem, Pc
264 E Broad St
Bethlehem
PA 18018-6224

Ph: (610) 866-9311

NPI Details:

NPI Number1518942655
Provider Enumeration Date12/13/2005
Last Update Date03/28/2008

Medicare PECOS Information:

Medicare PECOS PAC ID5395724025
Medicare Enrollment IDO20040716000314

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Psychology Associates Of Bethlehem, Pc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1518942655NPI-NPPES
747971OtherPAHIGHMARK
02372500OtherPACAPITAL BC
0698905000OtherPAINDEPENDENCE BC
5471610OtherPAAETNA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist PS005682L (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Psychology Associates Of Bethlehem, Pc acts as a billing entity for following providers:
Provider NameThomas D Sugalski
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1518954742
PECOS PAC ID: 8022006543
Enrollment ID: I20040504000599

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more Medical News

› Verified 2 days ago

Provider NameJoanne Marie Regina
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1760470090
PECOS PAC ID: 8224057799
Enrollment ID: I20060925000377

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more Medical News

› Verified 2 days ago

Provider NameScott J Bloszinsky
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1811985138
PECOS PAC ID: 6709901820
Enrollment ID: I20100914000101

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more Medical News

› Verified 2 days ago

Provider NameJennifer Lee Brisbane
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1548535057
PECOS PAC ID: 9537320460
Enrollment ID: I20120419000485

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more Medical News

› Verified 2 days ago

News Archive

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

Cost of uncompensated care for undocumented immigrants difficult to calculate, experts say

Pinpointing the exact cost of providing hospital care to undocumented immigrants in the U.S. is challenging for several reasons, according to government officials and health care experts, the Arkansas Democrat-Gazette reports.

Leading researchers reject proposed link between adeno-associated virus 2 and hepatocellular carcinoma

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was resoundingly rejected by leading researchers in the fields of gene therapy and molecular genetics.

Study identifies molecular signals that maintain nerve cell structures in the adult brain

Humans and other vertebrates depend on a portion of the brain called the hippocampus for learning, memory and their sense of location. Nerve cell structures in the adult hippocampus are sustained by factors whose identities have remained largely mysterious so far.

Read more News

› Verified 2 days ago

Psychologist in Bethlehem, PA

Vericare
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 724 Delaware Ave, Bethlehem, PA 18015
Phone: 800-257-8715    Fax: 800-819-1655
St. Luke's Pediatric Neurology
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 306 S New St Ste 303, Bethlehem, PA 18015
Phone: 484-526-5580    Fax: 833-214-7525
St Lukes Hospital
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 801 Ostrum St, Bethlehem, PA 18015
Phone: 610-954-4000    
Reset, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 23 E 3rd St, Bethlehem, PA 18015
Phone: 484-893-4545    
Valley Youth House Committee Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3400 High Point Blvd, Bethlehem, PA 18017
Phone: 610-820-0166    Fax: 267-930-4506
Center For Integrated Behavioral Health,llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1 Bethlehem Plz, Suite 810, Bethlehem, PA 18018
Phone: 610-865-4300    
Base Service Unit 392
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2604 Schoenersville Rd, Bethlehem, PA 18017
Phone: 610-691-8028    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.